HSV-1 exploits the innate immune scavenger receptor MARCO to enhance epithelial adsorption and infection

Nature Communications

Volumn 4, Issue , 2013, Pages

  MacLeod, Daniel T ^a   Nakatsuji, Teruaki ^a,b   Yamasaki, Kenshi ^a   Kobzik, Lester ^c   Gallo, Richard L ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MACROPHAGE RECEPTOR WITH COLLAGENOUS STRUCTURE; PROTEIN C; SCAVENGER RECEPTOR; UNCLASSIFIED DRUG; GLYCOPROTEIN GC, HERPES SIMPLEX VIRUS TYPE 1; IMMUNOGLOBULIN RECEPTOR; LIGAND; MARCO PROTEIN, HUMAN; MARCO PROTEIN, MOUSE; VIRUS ENVELOPE PROTEIN; PROTEIN BINDING;

ADSORPTION; ANTIVIRAL ACTIVITY; ARTICLE; CELL ACTIVATION; CELL SURFACE; CONTROLLED STUDY; CYTOKINE RELEASE; EPITHELIUM CELL; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 1; HOST RESISTANCE; INNATE IMMUNITY; KERATINOCYTE; NONHUMAN; SKIN INFECTION; VIRUS ENTRY; VIRUS PARTICLE; ANIMAL; CELL MEMBRANE; HUMAN; IMMUNOLOGY; ISOLATION AND PURIFICATION; METABOLISM; MOUSE; PATHOLOGY; PHYSIOLOGY; PROTEIN BINDING; PROTEIN TRANSPORT; VIRION; VIROLOGY;

HUMAN HERPESVIRUS 1; MUS;

ADSORPTION; ANIMALS; CELL MEMBRANE; EPITHELIAL CELLS; HERPES SIMPLEX; HERPESVIRUS 1, HUMAN; HUMANS; IMMUNITY, INNATE; KERATINOCYTES; LIGANDS; MICE; PROTEIN BINDING; PROTEIN TRANSPORT; RECEPTORS, IMMUNOLOGIC; RECEPTORS, SCAVENGER; VIRAL ENVELOPE PROTEINS; VIRION;

EID: 84891588068     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms2963     Document Type: Article

References (60)

1. WuDunn, D. & Spear, P. G. Initial interaction of herpes simplex virus with cells is binding to heparan sulfate. J. Virol. 63, 52-58 (1989).
2. Herold, B. C., Gerber, S. I., Belval, B. J., Siston, A. M. & Shulman, N. Differences in the susceptibility of herpes simplex virus types 1 and 2 to modified heparin compounds suggest serotype differences in viral entry. J. Virol. 70, 3461-3469 (1996).
3. Herold, B. C., WuDunn, D., Soltys, N. & Spear, P. G. Glycoprotein C of herpes simplex virus type 1 plays a principal role in the adsorption of virus to cells and in infectivity. J. Virol. 65, 1090-1098 (1991).
4. Tal-Singer, R. et al. Interaction of herpes simplex virus glycoprotein gC with mammalian cell surface molecules. J. Virol. 69, 4471-4483 (1995).
5. Herold, B. C., Visalli, R. J., Susmarski, N., Brandt, C. R. & Spear, P. G. Glycoprotein C-independent binding of herpes simplex virus to cells requires cell surface heparan sulphate and glycoprotein B. J. Gen. Virol. 75, 1211-1222 (1994).
6. Gallo, R., Kim, C., Kokenyesi, R., Adzick, N. S. & Bernfield, M. Syndecans-1 and -4 are induced during wound repair of neonatal but not fetal skin. J. Invest. Dermatol. 107, 676-683 (1996).
7. Shukla, D. et al. A novel role for 3-O-sulfated heparan sulfate in herpes simplex virus 1 entry. Cell 99, 13-22 (1999).
8. Geraghty, R. J., Krummenacher, C., Cohen, G. H., Eisenberg, R. J. & Spear, P. G. Entry of alphaherpesviruses mediated by poliovirus receptor-related protein 1 and poliovirus receptor. Science 280, 1618-1620 (1998).
9. Montgomery, R. I., Warner, M. S., Lum, B. J. & Spear, P. G. Herpes simplex virus-1 entry into cells mediated by a novel member of the TNF/NGF receptor family. Cell 87, 427-436 (1996).
10. Satoh, T. et al. PILRalpha is a herpes simplex virus-1 entry coreceptor that associates with glycoprotein B. Cell 132, 935-944 (2008).
11. Arii, J. et al. Non-muscle myosin IIA is a functional entry receptor for herpes simplex virus-1. Nature 467, 859-862 (2010).
12. Melchjorsen, J. Sensing herpes: more than toll. Rev. Med. Virol. 22, 106-121 (2011).
13. Saleh, M.-C. et al. The endocytic pathway mediates cell entry of dsRNA to induce RNAi silencing. Nat. Cell. Biol. 8, 793-802 (2006).
14. Limmon, G. V. et al. Scavenger receptor class-A is a novel cell surface receptor for double-stranded RNA. FASEB J 22, 159-167 (2008).
15. DeWitte-Orr, S. J., Collins, S. E., Bauer, C. M., Bowdish, D. M. & Mossman, K. L. An accessory to the 'Trinity': SR-As are essential pathogen sensors of extracellular dsRNA, mediating entry and leading to subsequent type I IFN responses. PLoS Pathog. 6, e1000829 (2010).
16. Matsumoto, M. et al. Subcellular localization of Toll-like receptor 3 in human dendritic cells. J. Immunol. 171, 3154-3162 (2003).
17. Yew, K. H., Carsten, B. & Harrison, C. Scavenger receptor A1 is required for sensing HCMV by endosomal TLR-3/-9 in monocytic THP-1 cells. Mol. Immunol. 47, 883-893 (2010).
18. Zhang, S.-Y. et al. TLR3 Deficiency in Patients with Herpes Simplex Encephalitis. Science 317, 1522-1527 (2007).
19. Casrouge, A. et al. Herpes Simplex Virus Encephalitis in Human UNC-93B Deficiency. Science 314, 308-312 (2006).
20. Perez de Diego, R. et al. Human TRAF3 adaptor molecule deficiency leads to impaired Toll-like receptor 3 response and susceptibility to herpes simplex encephalitis. Immunity 33, 400-411 (2010).
21. Sancho-Shimizu, V. et al. Herpes simplex encephalitis in children with autosomal recessive and dominant TRIF deficiency. J Clin. Invest. 121, 4889-4902 (2011).
22. Reinert, L. S. et al. TLR3 deficiency renders astrocytes permissive to herpes simplex virus infection and facilitates establishment of CNS infection in mice. J. Clin. Invest. 122, 1368-1376 (2012).
23. Jacobs, B. L. & Langland, J. O. When two strands are better than one: the mediators and modulators of the cellular responses to double-stranded RNA. Virology 219, 339-349 (1996).
24. Majde, J. A., Guha-Thakurta, N., Chen, Z., Bredow, S. & Krueger, J. M. Spontaneous release of stable viral double-stranded RNA into the extracellular medium by influenza virus-infected MDCK epithelial cells: implications for the viral acute phase response. Arch. Virol. 143, 2371-2380 (1998).
25. Lai, Y. et al. Commensal bacteria regulate Toll-like receptor 3-dependent inflammation after skin injury. Nat. Med. 15, 1377-1382 (2009).
26. Lebre, M. C. et al. Human keratinocytes express functional Toll-like receptor 3, 4, 5, and 9. J. Invest. Dermatol. 127, 331-341 (2007).
27. Kollisch, G. et al. Various members of the Toll-like receptor family contribute to the innate immune response of human epidermal keratinocytes. Immunology 114, 531-541 (2005).
28. Tohyama, M. et al. dsRNA-mediated innate immunity of epidermal keratinocytes. Biochem. Biophys. Res. Commun. 335, 505-511 (2005).
29. Alexopoulou, L., Holt, A. C., Medzhitov, R. & Flavell, R. A. Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature 413, 732-738 (2001).
30. Yamamoto, M. et al. Cutting edge: a novel Toll/IL-1 receptor domaincontaining adapter that preferentially activates the IFN-beta promoter in the Toll-like receptor signaling. J. Immunol. 169, 6668-6672 (2002).
31. Oshiumi, H., Matsumoto, M., Funami, K., Akazawa, T. & TICAM-1, Seya T. an adaptor molecule that participates in Toll-like receptor 3-mediated interferonbeta induction. Nat. Immunol. 4, 161-167 (2003).
32. Tabeta, K. et al. Toll-like receptors 9 and 3 as essential components of innate immune defense against mouse cytomegalovirus infection. Proc. Natl Acad. Sci. USA 101, 3516-3521 (2004).
33. Guillot, L. et al. Involvement of toll-like receptor 3 in the immune response of lung epithelial cells to double-stranded RNA and influenza A virus. J. Biol. Chem. 280, 5571-5580 (2005).
34. Mowen, K. A. et al. Arginine methylation of STAT1 modulates IFNalpha/betainduced transcription. Cell 104, 731-741 (2001).
35. Isaacs, A. & Lindenmann, J. Virus interference. I. The interferon. Proc. R Soc. Lond. B Biol. Sci. 147, 258-267 (1957).
36. Basler, C. F. & Garcia-Sastre, A. Viruses and the type I interferon antiviral system: Induction and evasion. Int. Rev. Immunol. 21, 305-337 (2009).
37. Krieger, M. et al. Molecular flypaper, host defense, and atherosclerosis. Structure, binding properties, and functions of macrophage scavenger receptors. J. Biol. Chem. 268, 4569-4572 (1993).
38. Rux, A. H. et al. Kinetic analysis of glycoprotein C of herpes simplex virus types 1 and 2 binding to heparin, heparan sulfate, and complement component C3b. Virology 294, 324-332 (2002).
39. Moriwaki, H. et al. Ligand specificity of LOX-1, a novel endothelial receptor for oxidized low density lipoprotein. Arterioscler. Thromb. Vasc. Biol. 18, 1541-1547 (1998).
40. Kodama, T. et al. Type I macrophage scavenger receptor contains alpha-helical and collagen-like coiled coils. Nature 343, 531-535 (1990).
41. Chen, Y. et al. A phage display screen and binding studies with acetylated low density lipoprotein provide evidence for the importance of the scavenger receptor cysteine-rich (SRCR) domain in the ligand-binding function of MARCO. J. Biol. Chem. 281, 12767-12775 (2006).
42. Ezzat, K. et al. Scavenger receptor-mediated uptake of cell-penetrating peptide nanocomplexes with oligonucleotides. FASEB J. 26, 1172-1180 (2011).
43. Cheshenko, N., Liu, W., Satlin, L. M. & Herold, B. C. Multiple receptor interactions trigger release of membrane and intracellular calcium stores critical for herpes simplex virus entry. Mol. Biol. Cell. 18, 3119-3130 (2007).
44. Bacsa, S. et al. Syndecan-1 and syndecan-2 play key roles in herpes simplex virus type 1 infection. J. Gen. Virol. 92, 733-743 (2011).
45. Rager-Zisman, B. & Allison, A. C. Mechanism of immunologic resistance to herpes simplex virus 1 (HSV-1) infection. J. Immunol. 116, 35-40 (1976).
46. Banfield, B. W., Leduc, Y., Esford, L., Schubert, K. & Tufaro, F. Sequential isolation of proteoglycan synthesis mutants by using herpes simplex virus as a selective agent: evidence for a proteoglycan-independent virus entry pathway. J. Virol. 69, 3290-3298 (1995).
47. Baba, M., Snoeck, R., Pauwels, R. & de Clercq, E. Sulfated polysaccharides are potent and selective inhibitors of various enveloped viruses, including herpes simplex virus, cytomegalovirus, vesicular stomatitis virus, and human immunodeficiency virus. Antimicro. Agents Chermother. 32, 1742-1745 (1988).
48. Mukhopadhyay, S. et al. SR-A/MARCO-mediated ligand delivery enhances intracellular TLR and NLR function, but ligand scavenging from cell surface limits TLR4 response to pathogens. Blood 117, 1319-1347 (2011).
49. Kurt-Jones, E. A. et al. Herpes simplex virus 1 interaction with Toll-like receptor 2 contributes to lethal encephalitis. Proc. Natl Acad. Sci. USA 101, 1315-1320 (2004).
50. Lubinski, J. M. et al. Herpes simplex virus type 1 evades the effects of antibody and complement in vivo. J. Virol. 76, 9232-9241 (2002).
51. Blyth, W. A., Harbour, D. A. & Hill, T. J. Pathogenesis of zosteriform spread of herpes simplex virus in the mouse. J. Gen. Virol. 65, 1477-1486 (1984).
52. Suzuki, H. et al. A role for macrophage scavenger receptors in atherosclerosis and susceptibility to infection. Nature 386, 292-296 (1997).
53. Haisma, H. J. et al. Scavenger Receptor A: A New Route for Adenovirus 5. Mol. Pharm. 6, 366-374 (2009).
54. Ghosh, S., Gregory, D., Smith, A. & Kobzik, L. MARCO regulates early inflammatory responses against influenza: A useful macrophage function with adverse outcome. Am. J. Respir. Cell. Mol. Biol. 45, 1036-1044 (2011).
55. Schauber, J. et al. Injury enhances TLR2 function and antimicrobial peptide expression through a vitamin D-dependent mechanism. J. Clin. Invest. 117, 803-811 (2007).
56. Nizet, V. et al. Innate antimicrobial peptide protects the skin from invasive bacterial infection. Nature 414, 454-457 (2001).
57. Edwards, L. et al. Self-administered topical 5% imiquimod cream for external anogenital warts. HPV study group. Human papillomavirus. Arch. Dermatol. 134, 25-30 (1998).
58. Stanley, M. A. Imiquimod and the imidazoquinolones: mechanism of action and therapeutic potential. Clin. Exp. Dermatol. 27, 571-577 (2002).
59. Sankala, M. et al. Characterization of recombinant soluble macrophage scavenger receptor MARCO. J. Biol. Chem. 277, 33378-33385 (2002).
60. Arredouani, M. S. et al. MARCO is the major binding receptor for unopsonized particles and bacteria on human alveolar macrophages. J. Immunol. 175, 6058-6064 (2005).